Press Releases

Date	Title	Company
06-Jul-2023	Multiplex Biomarker Imaging Market is expected to reach US$ 1,041.7 Million by 2029 Advancing Precision Medicine and Personalized Diagnostics	MARKITWIRED
06-Jul-2023	Dermal Fillers and Botulinum Toxin Market is projected to reach a valuation of US$ 10.5 Billion by 2032: A Growing Aesthetic Intervention Trend	MARKITWIRED
06-Jul-2023	Empowering Animal Health: Farm Animal Drugs Market is projected to reach a valuation of US$ 29.4 Billion by 2032 Drives Growth and Well-being	MARKITWIRED
06-Jul-2023	Revolutionizing Medication Release: Oral Controlled Release Drug Delivery Technology Market is expected to reach US$ 68.4 billion by 2032 Surges Ahead	MARKITWIRED
06-Jul-2023	Expanding Horizons: Oral Solid Dosage Pharmaceutical Formulation Market on the Rise is expected to surpass a valuation of US$ 1.0 Billion by 2032	MARKITWIRED
06-Jul-2023	Medical Bionic Implants and Exoskeletons Market to Garner US$ 1.5 Billion by 2032 Due to Advancements in Bionic Technology	MARKITWIRED
06-Jul-2023	Thriving Opportunities in the Dental Caries and Endodontic Market is totaling US$ 56.5 Billion by 2032: Innovations in Oral Healthcare	MARKITWIRED
06-Jul-2023	Advancements in Cancer Diagnostics Market is expected to reach at a CAGR of 7.1 %, US$ 379 Billion by 2032: A Booming for Precision Medicine	MARKITWIRED
06-Jul-2023	Cantourage Group SE announces partnership with Canadian grower Costa Canna	Cantourage Group SE
06-Jul-2023	Douglas GmbH: Standard & Poor’s upgrades DOUGLAS‘ outlook to stable, affirms rating	Douglas GmbH
06-Jul-2023	AEVIS VICTORIA SA – Fabrice Zumbrunnen joins the Board of Directors of Swiss Medical Network SA	AEVIS VICTORIA SA
06-Jul-2023	Gerresheimer AG: Gerresheimer continues dynamic growth in first half of 2023	Gerresheimer AG
06-Jul-2023	Biocytogen Pharmaceuticals Enters Into License Agreement With Pheon Therapeutics	Businesswire
05-Jul-2023	Teva to Host Conference Call to Discuss Second Quarter 2023 Financial Results at 8 a.m. ET on August 2, 2023	Businesswire
05-Jul-2023	Medpace Holdings, Inc. to Report Second Quarter 2023 Financial Results on July 24, 2023	Businesswire
05-Jul-2023	Verastem Oncology Announces Design for Confirmatory Trial of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer	Businesswire
05-Jul-2023	ADOCIA Grants Sanofi an Exclusive Right to Negotiate a Partnership on M1Pram for 10 Million Euros and Obtains Commitment from Investors to Provide 10 Million Euros in Financing	Businesswire
05-Jul-2023	Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of June 30th, 2023	Businesswire
05-Jul-2023	IQVIA and the NBA Selected for Abbott’s UNIVANTS of Healthcare Excellence Award	Businesswire
05-Jul-2023	Propanc Biopharma Produces Synthetic Recombinant Proenzymes for Cancer Therapy Targeting Advanced Solid Tumors	Businesswire